Literature DB >> 2788743

Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'-tetrasubstituted, long-chain dioic acids.

J Bar-Tana1, S Ben-Shoshan, J Blum, Y Migron, R Hertz, J Pill, G Rose-Khan, E C Witte.   

Abstract

beta,beta,beta',beta'-Tetrasubstituted, long-chain dioic acids of the general formula HOOC-C(XY)-C(R2)-Q-C-(R2)-C(XY)-COOH have been synthesized and evaluated as hypotriglyceridemic-hypocholesterolemic agents in rats and as antidiabetogenic agents in ob/ob diabetic mice. The free carboxyl function of analogues of the series was mandatory for their hypolipidemic-antidiabetogenic effect while nonhydrolyzable diesters were inactive. Other structure-activity relationships were determined as a function of the overall chain length (C12-C22), alpha,alpha'-substitutions (X, Y = H, F, Cl, Br, OH, CN), beta, beta'-substitutions (R = CH3, C6H5), and core substitutions [Q = (CH2)10, (CH2)4CH = CH(CH2)4, 1,4-C6H10[(CH2)3]2, 1,4-C6H4[(CH2)3]2, 1,4-C6H4(CH = CHCH2)2, CH2(OCH2CH2)3OCH2)]. The most effective hypolipidemic-antidiabetogenic members of the series were alpha,alpha'-nonsubstituted, beta,beta'-methyl-substituted analogues of 14-18-carbon chains having either a saturated aliphatic core or a 1,4-bis(propenyl)benzene core in the cis/trans configuration. The hypotriglyceridemic rather than the hypocholesterolemic capacity of members of the series was found to correlate with their respective capacities as liver peroxisomal proliferators in rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788743     DOI: 10.1021/jm00129a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Thyromimetic effect of peroxisomal proliferators in rat liver.

Authors:  R Hertz; R Aurbach; T Hashimoto; J Bar-Tana
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

2.  Hypocholesterolaemic effect of beta beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in the male hamster.

Authors:  N Mayorek; J Bar-Tana
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

3.  AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.

Authors:  Stephen L Pinkosky; Sergey Filippov; Rai Ajit K Srivastava; Jeffrey C Hanselman; Cheryl D Bradshaw; Timothy R Hurley; Clay T Cramer; Mark A Spahr; Ashley F Brant; Jacob L Houghton; Chris Baker; Mark Naples; Khosrow Adeli; Roger S Newton
Journal:  J Lipid Res       Date:  2012-11-01       Impact factor: 5.922

4.  The effect of beta,beta'-tetramethylhexadecanedioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: role of apolipoprotein C-III.

Authors:  B Frenkel; J Bishara-Shieban; J Bar-Tana
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

Review 5.  AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.

Authors:  Rai Ajit K Srivastava; Stephen L Pinkosky; Sergey Filippov; Jeffrey C Hanselman; Clay T Cramer; Roger S Newton
Journal:  J Lipid Res       Date:  2012-07-13       Impact factor: 5.922

6.  Gating of the mitochondrial permeability transition pore by long chain fatty acyl analogs in vivo.

Authors:  Dmitri Samovski; Bella Kalderon; Einav Yehuda-Shnaidman; Jacob Bar-Tana
Journal:  J Biol Chem       Date:  2009-12-26       Impact factor: 5.157

7.  Suppression of FoxO1 activity by long-chain fatty acyl analogs.

Authors:  Ghadeer Zatara; Rachel Hertz; Maayan Shaked; Nina Mayorek; Etedal Morad; Etty Grad; Amos Cahan; Haim D Danenberg; Terry G Unterman; Jacob Bar-Tana
Journal:  Diabetes       Date:  2011-05-20       Impact factor: 9.461

8.  Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate.

Authors:  Cristina Menni; Delyth Graham; Gabi Kastenmüller; Nora H J Alharbi; Safaa Md Alsanosi; Martin McBride; Massimo Mangino; Philip Titcombe; So-Youn Shin; Maria Psatha; Thomas Geisendorfer; Anja Huber; Annette Peters; Rui Wang-Sattler; Tao Xu; Mary Julia Brosnan; Jeff Trimmer; Christian Reichel; Robert P Mohney; Nicole Soranzo; Mark H Edwards; Cyrus Cooper; Alistair C Church; Karsten Suhre; Christian Gieger; Anna F Dominiczak; Tim D Spector; Sandosh Padmanabhan; Ana M Valdes
Journal:  Hypertension       Date:  2015-06-01       Impact factor: 10.190

9.  Prevention of diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic.

Authors:  Anna Algamas-Dimantov; Einav Yehuda-Shnaidman; Rachel Hertz; Irena Peri; Jacob Bar-Tana; Betty Schwartz
Journal:  Oncotarget       Date:  2014-10-30

10.  Suppression of B-Raf(V600E) cancers by MAPK hyper-activation.

Authors:  Rawan Atiq; Rachel Hertz; Sophia Eldad; Elia Smeir; Jacob Bar-Tana
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.